Clinical Trials for Plasma Cell Leukemia

Find clinical trials for plasma cell leukemia. Discover research opportunities and treatment options in your area.

20 Active Trials Found

Showing 20 trials on this page

Page 1 of 1

Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

NCT ID: NCT03314974

This clinical trial is studying a type of treatment called allogeneic hematopoietic stem cell transplant (HCT) for patients with various blood cancers, including leukemia and lymphoma. The aim is t...

Recruiting

Phase: PHASE2 Type: interventional Locations: Minneapolis, Minnesota, United States

A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia

NCT ID: NCT05219721

This clinical trial is testing a new treatment called CAR-GPRC5D for patients with relapsed or refractory multiple myeloma and plasma cell leukemia. This means the study is looking at how well this...

Recruiting

Phase: PHASE1 Type: interventional Locations: Wuhan, Hu Bei, China

Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances

NCT ID: NCT05092451

This clinical trial is exploring a new treatment approach for patients with certain blood cancers, including B-Cell Lymphoma, Myelodysplastic Syndromes (MDS), and Acute Myeloid Leukemia (AML). The ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

A Study of CT0596 in Plasma Cell Leukemia

NCT ID: NCT06988059

This clinical trial is investigating a new treatment called CT0596 for patients with Plasma Cell Leukemia (PCL), a type of blood cancer. The study aims to understand how safe and effective this tre...

Not yet recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Tianjin, Tianjin, China

A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia

NCT ID: NCT05759793

This clinical trial is investigating a new treatment called CAR-GPRC5D for patients with relapsed or refractory multiple myeloma (a type of blood cancer) or plasma cell leukemia. The goal is to see...

Recruiting

Phase: PHASE1 Type: interventional Locations: Shanghai, , China

Allo HSCT Using RIC and PTCy for Hematological Diseases

NCT ID: NCT05805605

This clinical trial is looking at a new approach to treating certain blood cancers, including various types of leukemia and lymphoma. The study is specifically evaluating a method called "Allo HSCT...

Recruiting

Phase: PHASE2 Type: interventional Locations: Minneapolis, Minnesota, United States

Use of Isatuximab, Dexamethasone and Lenalidomide in a Go-Slow Fashion for Ultra-Frail Patients With Multiple Myeloma

NCT ID: NCT06517017

This clinical trial is exploring a new way to treat ultra-frail patients with multiple myeloma and plasma cell leukemia. The researchers believe that starting treatment slowly and gently, using a c...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Salt Lake City, Utah, United States

European Myeloma Network (EMN) Sample Project

NCT ID: NCT06237803

The European Myeloma Network (EMN) Sample Project is a clinical study focused on collecting and analyzing biological samples from patients with conditions related to multiple myeloma, including smo...

Recruiting

Type: observational Locations: Brescia, , Italy, Terni, , Italy +28 more

The Norwegian Immunotherapy in Multiple Myeloma Study

NCT ID: NCT06855121

The Norwegian Immunotherapy in Multiple Myeloma Study is a research project looking at new treatments for multiple myeloma and related conditions, such as plasma cell leukemia and AL amyloidosis. T...

Recruiting

Type: observational Locations: Haugesund, , Norway, Stavanger, , Norway +21 more

Cancer and Aging Resilience Evaluation in Older Adults with Hematologic Malignancies: the CARE-Heme Registry

NCT ID: NCT05556928

The CARE-Heme Registry is a clinical trial focused on understanding the health of older adults (age 50 and above) who have specific blood cancers, such as Multiple Myeloma, Amyloidosis, and Plasma ...

Recruiting

Type: observational Locations: Birmingham, Alabama, United States

Registry for Adults With Plasma Cell Disorders (PCD's)

NCT ID: NCT03717844

This clinical trial is focused on creating a registry for adults who have plasma cell disorders (PCDs), which are conditions like multiple myeloma, amyloidosis, and several others that affect the p...

Recruiting

Type: observational Locations: Chapel Hill, North Carolina, United States

Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases

NCT ID: NCT01962636

This clinical trial is investigating a treatment called umbilical cord blood transplantation (UCBT) for patients with specific blood cancers, including different types of leukemia and lymphoma. The...

Recruiting

Phase: NA Type: interventional Locations: Minneapolis, Minnesota, United States

An Exploratory Study of RD140 Injection in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia

NCT ID: NCT06655519

This clinical trial is exploring the safety and effectiveness of a new treatment called RD140 injection for patients with relapsed or refractory multiple myeloma and plasma cell leukemia. These con...

Not yet recruiting

Phase: PHASE1 Type: interventional

Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients

NCT ID: NCT05823571

This clinical trial is investigating whether a new drug called itacitinib can help prevent complications after a type of stem cell transplant known as a 'mini' transplant. This transplant uses stem...

Recruiting

Phase: PHASE1 Type: interventional Locations: Baltimore, Maryland, United States

A Study of VRD-based Regimen Combined With CART-ASCT-CART2 Treatment in Patients With Primary Plasma Cell Leukemia

NCT ID: NCT05870917

This clinical trial is exploring a new treatment approach for patients with primary plasma cell leukemia (pPCL), a type of blood cancer. The study is testing a combination of three medications—Bort...

Recruiting

Phase: PHASE2 Type: interventional Locations: Tianjin, , China

To Evaluate the Safety and Efficacy of Human BCMA Targeted CAR-NK Cells Injection for Subjects With R/R MM or PCL

NCT ID: NCT06045091

This clinical trial is investigating a new treatment using a special type of immune cells, called CAR-NK cells, designed to target cancer cells in patients with relapsed or refractory multiple myel...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Shanghai, Shanghai, China

A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by BCMA CAR-T Therapy in Transplant-Ineligible Patients With Primary Plasma Cell Leukemia

NCT ID: NCT05979363

This clinical trial is studying the effects of a combination treatment called VRd (which includes medications bortezomib, lenalidomide, and dexamethasone) followed by a type of immune therapy known...

Recruiting

Phase: PHASE2 Type: interventional Locations: Tianjin, , China

CT0594CP CAR-T Cells in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia

NCT ID: NCT05822037

This clinical trial is studying a new treatment called CT0594CP CAR-T Cells for patients with relapsed or refractory multiple myeloma and plasma cell leukemia. Essentially, this treatment aims to h...

Recruiting

Phase: NA Type: interventional Locations: Suzhou, Jiangsu, China

A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

NCT ID: NCT05283993

This clinical trial is focused on understanding various plasma cell disorders (PCDs), which include conditions like multiple myeloma and amyloidosis, among others. The goal is to create a group of ...

Recruiting

Type: observational Locations: Beijing, , China

Primary Plasma Cell Leukemia: a Prospective Phase 2 Study Incorporating Daratumumab to Chemotherapy and Stem Cell Transplantation

NCT ID: NCT05054478

This clinical trial is researching a new treatment approach for patients with primary plasma cell leukemia, a type of blood cancer. The study aims to see how effective a combination of a medication...

Not yet recruiting

Phase: PHASE2 Type: interventional

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions